Christine Pellizzari
2017 - INSMED
In 2017, Christine Pellizzari earned a total compensation of $2M as Chief Legal Officer at INSMED, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $270,000 |
|---|---|
| Option Awards | $1,284,425 |
| Salary | $415,340 |
| Other | $8,100 |
| Total | $1,977,865 |
Pellizzari received $1.3M in option awards, accounting for 65% of the total pay in 2017.
Pellizzari also received $270K in non-equity incentive plan, $415.3K in salary and $8.1K in other compensation.
Rankings
In 2017, Christine Pellizzari's compensation ranked 5,550th out of 14,666 executives tracked by ExecPay. In other words, Pellizzari earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,550 out of 14,666 | 62nd |
Division Manufacturing | 2,004 out of 5,772 | 65th |
Major group Chemicals And Allied Products | 613 out of 2,075 | 71st |
Industry group Drugs | 472 out of 1,731 | 73rd |
Industry Pharmaceutical Preparations | 369 out of 1,333 | 72nd |
Source: SEC filing on April 5, 2018.
Pellizzari's colleagues
We found seven more compensation records of executives who worked with Christine Pellizzari at INSMED in 2017.
2017
William Lewis
INSMED
Chief Executive Officer
2017
Roger Adsett
INSMED
Chief Commercial Officer
2017
Paolo Tombesi
INSMED
Chief Financial Officer
2017
S Schaeffer
INSMED
Chief People Strategy Officer
2017
Paul Streck
INSMED
Chief Medical Officer
2017
John Goll
INSMED
Former Principal Financial Officer
2017
Andrew Drechsler
INSMED
Chief Financial Officer
News
Science 37 Holdings CEO David Coman's 2022 pay slips 4% to $8.1M
March 20, 2023
Science 37 Holdings CEO David Coman's 2021 pay jumps 656% to $8.4M
March 23, 2022
INSMED CEO William Lewis' 2020 pay slips 14% to $6.2M
April 1, 2021
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019